Medicago’s COVID-19 vaccine elicits immune response in early-stage study
Medicago did not disclose full safety data, but said side effects were mainly mild to moderate
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Medicago
Canada to invest up to C$214 mn for R&D of home grown COVID-19 vaccines: Trudeau
It has secured up to 76 million doses of Quebec City-based Medicago’s potential vaccine
Medicago announces production of a viable vaccine candidate for COVID-19
The biopharma successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based…